4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Osteomyelitis: new trials by email Literature Review of Osteomyelitis trials Research Report on Osteomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections sodium fusidate - Refractory Bone or Joint Infections | Phase 2 / Phase 3 | Completed | Arrevus Inc. | 30 | 2015-12-01 | 2020-01-30 |
| Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061) Ertapenem sodium, Piperacillin/tazobactam sodium, Piperacillin/tazobactam-matching placebo - Infection; Diabetic Foot | Phase 3 | Completed | Merck Sharp & Dohme LLC | 565 | 2011-09-02 | 2018-08-27 |
| Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. Tigecycline, Ertapenem - Bacterial Infections, Diabetic Foot | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 1061 | 2007-01-01 | 2010-04-28 |
| Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis trimethoprim-sulfamethoxazole, vancomycin - Osteomyelitis, Methicillin-resistant Staphylococcus Aureus | Phase 3 | Completed | University of Washington | 2 | 2006-05-01 | 2023-04-11 |
Diabetes Complications (2) · Diabetic Foot (2) · Bacterial Infections (1) · Cellulitis (1) · Diabetes Mellitus (1) · Foot Ulcer (1) · Infections (1) · Soft Tissue Infections (1)
Bone Diseases (4) · Bone Diseases, Infectious (4) · Musculoskeletal Diseases (4) · Infections (3) · Cardiovascular Diseases (2) · Diabetic Angiopathies (2) · Diabetic Neuropathies (2) · Endocrine System Diseases (2) · Leg Ulcer (2) · Skin Diseases (2) · Skin Ulcer (2) · Skin and Connective Tissue Diseases (2) · Vascular Diseases (2) · Bacterial Infections and Mycoses (1) · Connective Tissue Diseases (1)
Ertapenem (2) · Amoxicillin (1) · Fusidic Acid (1) · L 749345 (1) · Piperacillin (1) · Piperacillin, Tazobactam Drug Combination (1) · Tazobactam (1) · Tigecycline (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · Vancomycin (1)
Arrevus Inc. (1) · Merck Sharp & Dohme LLC (1) · University of Washington (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (3) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · China (1) · Colombia (1) · Croatia (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1)
Christian Ramers, MD (1) · Jeanne Chan, PharmD, MPH (1) · Jeanne M Marrazzo, MD, MPH (1) · Lisa Taitsman, MD (1) · M. Bradford Henley, MD (1) · Matthew Golden, MD, MPH (1) · Robert D Harrington, MD (1) · Robert Dobbins, MD, PhD (1) · Thomas R Hawn, MD, PhD (1) · Timothy H. Dellitt, MD (1)